RMA is selling a new “dreaded disease” product

Royale Marocaine d’Assurance (RMA) is marketing a new coverage against dreaded diseases. The pathologies targeted are namely cancer, CVA, myocardial infarction, coronary artery diseases, terminal kidney failures, organ transplant, sclerosis, benign brain tumors, terminal liver failure and total sight loss.

This product makes it possible to pay policyholders suffering from the afore-mentioned diseases a lump sum benefit worth between 150 000 and 750 000 MAD (15 874 to 79 373 USD) according to the formula chosen during the signing of the contract.

Read also:

• RMA exhibits good performance in 2017